| Followers | 18 |
| Posts | 26514 |
| Boards Moderated | 0 |
| Alias Born | 09/05/2002 |
Friday, November 01, 2002 6:11:05 PM
their business model prevents them from risking it. they are making a solid year by year return on what they are doing. when medicis took on the psoriasis vaccine, they ended up two years later letting the vp of business out the door. ( never did find out what the end of the story was)
its like my stock trading. as soon as i make a few hundred a trade, the next one I dont put a stop on kills me. or after losing a few I decide the market will never go up. its tough to know what to do if you are in business development. I think they will prefer to take over late phase two or phase three drugs and pay a premium than do it. Find to do but if a company thinks they have a winner, sometimes its hard to buy it.
So big pharma has a general caldron of creatures running around, and they hope they will catch one before it gets a way.
little pharma does not have the risk money to do it.
I am certainly not downplaying the stock now. But when it becomes generally obvious that there are some cool new things going on in dermatology, probably someone like galderma will be the one to do it and they are private. this could take several more years to do.
And I do NOT know what Medicis has up their sleeve. they could be fully loaded. find out at the next cc.
its like my stock trading. as soon as i make a few hundred a trade, the next one I dont put a stop on kills me. or after losing a few I decide the market will never go up. its tough to know what to do if you are in business development. I think they will prefer to take over late phase two or phase three drugs and pay a premium than do it. Find to do but if a company thinks they have a winner, sometimes its hard to buy it.
So big pharma has a general caldron of creatures running around, and they hope they will catch one before it gets a way.
little pharma does not have the risk money to do it.
I am certainly not downplaying the stock now. But when it becomes generally obvious that there are some cool new things going on in dermatology, probably someone like galderma will be the one to do it and they are private. this could take several more years to do.
And I do NOT know what Medicis has up their sleeve. they could be fully loaded. find out at the next cc.
Recent MRX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:05:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:05:02 PM
- Form 13F-HR - Quarterly report filed by institutional managers, Holdings • Edgar (US Regulatory) • 04/02/2026 01:27:46 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/01/2026 08:56:08 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 04/01/2026 06:45:26 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 04/01/2026 06:40:57 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 04/01/2026 06:29:03 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 03/31/2026 03:57:13 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 03/30/2026 03:34:58 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/26/2026 12:18:14 PM
- Marex Group plc announces Q1 trading update and hosts Investor Day in New York • GlobeNewswire Inc. • 03/26/2026 12:00:00 PM
- Marex Group plc files its Annual Report on Form 20-F • GlobeNewswire Inc. • 03/25/2026 09:46:27 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/25/2026 09:15:32 PM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/25/2026 09:07:49 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 08:05:21 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 08:05:18 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 08:05:17 PM
